David Peterhoff
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 26
- SARS-CoV-2 detection and testing 6
- COVID-19 Clinical Research Studies 2
- Virology 14
- HIV Research and Treatment 14
- Co-authors
- Ralf Wagner (28 shared papers)André Gessner (13 shared papers)Miriam Breunig (7 shared papers)Bernd Salzberger (8 shared papers)Oscar Paul Kuipers (2 shared papers)Bárbara Schmidt (9 shared papers)Benedikt Asbach (7 shared papers)Sven Panke (1 shared paper)
- Journals
- Frontiers in Immunology (7 papers)Vaccines (6 papers)Infection (4 papers)European Journal of Pharmaceutics and Biopharmaceutics (3 papers)Viruses (2 papers)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
David Peterhoff
58 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Infectious Diseases 587
- Virology 71
- Microbiology 46
- Modeling and Simulation 25
- Pharmacology 62
Countries citing papers authored by David Peterhoff
This map shows the geographic impact of David Peterhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Peterhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Peterhoff more than expected).
Fields of papers citing papers by David Peterhoff
This network shows the impact of papers produced by David Peterhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Peterhoff. The network helps show where David Peterhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside David Peterhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 123 | |
| 2 | 2019 | 97 | |
| 3 | 2021 | 94 | |
| 4 | 2023 | 60 | |
| 5 | 2021 | 42 | |
| 6 | 2021 | 41 | |
| 7 | 2021 | 41 | |
| 8 | 2021 | 37 | |
| 9 | 2021 | 30 | |
| 10 | 2022 | 30 | |
| 11 | 2021 | 28 | |
| 12 | 2021 | 28 | |
| 13 | 2021 | 27 | |
| 14 | 2019 | 25 | |
| 15 | 2014 | 24 | |
| 16 | 2018 | 23 | |
| 17 | 2019 | 23 | |
| 18 | 2023 | 21 | |
| 19 | 2023 | 20 | |
| 20 | 2021 | 17 |
About David Peterhoff
David Peterhoff is a scholar working on Infectious Diseases, Virology, Microbiology, Modeling and Simulation and Biochemistry, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (26 papers), HIV Research and Treatment (14 papers), SARS-CoV-2 detection and testing (6 papers), Antimicrobial Peptides and Activities (3 papers), COVID-19 Clinical Research Studies (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Long-Term Effects of COVID-19 (2 papers) and Plant biochemistry and biosynthesis (2 papers). The work is most often cited by research in Infectious Diseases (587 citations), Virology (71 citations), Microbiology (46 citations), Modeling and Simulation (25 citations) and Pharmacology (62 citations). David Peterhoff has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Ralf Wagner, André Gessner, Miriam Breunig, Bernd Salzberger, Oscar Paul Kuipers, Bárbara Schmidt, Benedikt Asbach, Sven Panke, Jingjing Deng and Manuel Montalbán‐López. Their work appears in journals such as Frontiers in Immunology, Vaccines, Infection, European Journal of Pharmaceutics and Biopharmaceutics and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.